ROTHBLATT MARTINE A (Chairperson & CEO) sold 19.0% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.22M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$146.03
Trade value
$1.39M
% of position
Common Stock
Shares
−75.00
Price / share
$538.85
Trade value
$40.41K
% of position
Common Stock
Shares
−205.00
Price / share
$540.43
Trade value
$110.79K
% of position
Common Stock
Shares
−200.00
Price / share
$541.61
Trade value
$108.32K
% of position
Common Stock
Shares
−440.00
Price / share
$543.51
Trade value
$239.14K
% of position
Common Stock
Shares
−809.00
Price / share
$545.51
Trade value
$441.32K
% of position
Common Stock
Shares
−470.00
Price / share
$546.22
Trade value
$256.73K
% of position
Common Stock
Shares
−482.00
Price / share
$547.63
Trade value
$263.96K
% of position
Common Stock
Shares
−1.46K
Price / share
$548.53
Trade value
$800.30K
% of position
Common Stock
Shares
−732.00
Price / share
$549.56
Trade value
$402.28K
% of position
Common Stock
Shares
−1.77K
Price / share
$550.72
Trade value
$973.66K
% of position
Common Stock
Shares
−1.18K
Price / share
$551.57
Trade value
$650.85K
% of position
Common Stock
Shares
−760.00
Price / share
$552.59
Trade value
$419.97K
% of position
Common Stock
Shares
−920.00
Price / share
$553.47
Trade value
$509.20K
% of position
Net shares
+0.00
Net value
-$3.83M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2026 | M · Option Exercise | +9.50K | $146.03 | $1.39M | 23.4% | 40.51K | 50.01K |
| Common Stock Direct | 6/15/2026 | S · Sale | −75.00 | $538.85 | $40.41K | 0.1% | 50.01K | 49.94K |
| Common Stock Direct | 6/15/2026 | S · Sale | −205.00 | $540.43 | $110.79K | 0.4% | 49.94K | 49.73K |
| Common Stock Direct | 6/15/2026 | S · Sale | −200.00 | $541.61 | $108.32K | 0.4% | 49.73K | 49.53K |
| Common Stock Direct | 6/15/2026 | S · Sale | −440.00 | $543.51 | $239.14K | 0.9% | 49.53K | 49.09K |
| Common Stock Direct | 6/15/2026 | S · Sale | −809.00 | $545.51 | $441.32K | 1.6% | 49.09K | 48.28K |
| Common Stock Direct | 6/15/2026 | S · Sale | −470.00 | $546.22 | $256.73K | 1.0% | 48.28K | 47.81K |
| Common Stock Direct | 6/15/2026 | S · Sale | −482.00 | $547.63 | $263.96K | 1.0% | 47.81K | 47.33K |
| Common Stock Direct | 6/15/2026 | S · Sale | −1.46K | $548.53 | $800.30K | 3.1% | 47.33K | 45.87K |
| Common Stock Direct | 6/15/2026 | S · Sale | −732.00 | $549.56 | $402.28K | 1.6% | 45.87K | 45.14K |
| Common Stock Direct | 6/15/2026 | S · Sale | −1.77K | $550.72 | $973.66K | 3.9% | 45.14K | 43.37K |
| Common Stock Direct | 6/15/2026 | S · Sale | −1.18K | $551.57 | $650.85K | 2.7% | 43.37K | 42.19K |
| Common Stock Direct | 6/15/2026 | S · Sale | −760.00 | $552.59 | $419.97K | 1.8% | 42.19K | 41.43K |
| Common Stock Direct | 6/15/2026 | S · Sale | −920.00 | $553.47 | $509.20K | 2.2% | 41.43K | 40.51K |
| Total | +0.00 | -$3.83M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
146.03
Held after
31.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock9.50K shares | 6/15/2026 | M · Option Exercise | −9.50K | 146.03 | — | 31.41K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 166.00 | Indirect |
| Common Stock | 249.11K | Indirect |
| Common Stock | 8.90K | Indirect |
| Common Stock | 45.60K | Indirect |
| Common Stock | 324.44K | Indirect |
| Total | 628.22K | 628.22K indirect |